News

Welcome to the news and media section of our website, where we feature corporate news releases and media coverage of interest.

 

mare and foal

Positive Effect of Settle® on Postpartum Involution Published in the Journal of Equine Veterinary Science

Data from a study with Settle® has been published in the Journal of Equine Veterinary Science. The data show a positive effect of Settle on postpartum uterine involution in the mare, particularly with a two-dose regimen.

mare and foal

Researchers Present Settle® Data to International Veterinary Scientists in Germany

Data from a University of Kentucky study assessing the effect of Settle on histological involution, cell-mediated immunity of the uterus, and clinical endpoints associated with involution was presented in Germany today.

dog from study on day of last treatment

Immunocidin® with Chemotherapy Extends Survival Time in Study with Canine Lymphoma and Osteosarcoma Patients

Positive data from a retrospective study using Immunocidin® with chemotherapy in dogs with Lymphoma and Osteosarcoma were presented at the Veterinary Cancer Society Annual Conference by Dr. Jeannette Kelly, vet oncologist.

2 Jersey calves

Amplimune® Administered in Calves Prior to Shipment Shows Economic Benefit

Data from a University of Minnesota research study presented by Dr. Luciano Caixeta at the AABP annual conference in St. Louis, MO last week shows an economic benefit to the use of Amplimune in calves prior to shipping.

2 Jersey calves

Amplimune® Administered in Calves Prior to Shipment Demonstrates a Reduced Likelihood of Pneumonia Upon Arrival

Amplimune® given to calves prior to shipment has been shown to reduce the likelihood of pneumonia on arrival. Data from a 1,360-calf study was presented at the 2019 American Dairy Science Association Annual Meeting today.

vial of Immunocidin

ISU College of Veterinary Medicine to Conduct a Study with Immunocidin® in the Treatment of Canine Hemangiosarcoma

NovaVive's anticancer immunotherapeutic for dogs will be evaluated in a clinical study at Iowa State University (ISU) College of Veterinary Medicine in the treatment of splenic hemangiosarcoma (in combination with chemo).

Sign up to stay up-to-date with NovaVive news.